Redera, Rhea Mae .
HRN: 26-00-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
METRONIDAZOLE 500MG (TAB)
10/14/2024
10/20/2024
PO
500mg
Tid
Post Partum R/o Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes